ReclutandoNCT07241390
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
Fase 3Eli Lilly and Company
Condiciones: Atherosclerosis Cardiovascular Disease, Chronic Kidney Disease
Sedes en Monterrey: CEINV Salud · Cardiolink Clin Trials · Servicios de Oncología Medica Integral - Monterrey - José Benitez
Ver registro oficial ↗ReclutandoNCT07293351
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
Fase 1 / Fase 2Bristol-Myers Squibb
Condiciones: Advanced Renal Cell Carcinoma (RCC)
Sedes en Monterrey: Local Institution - 0046
Ver registro oficial ↗ReclutandoNCT07355296
PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Fase 2Boehringer Ingelheim
Condiciones: Proteinuric Kidney Diseases
Sedes en Monterrey: Servicios de Oncología Medica Integral, S.A de C.V. Sucursal Renal
Ver registro oficial ↗ReclutandoNCT05457283
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
Fase 3Bayer
Condiciones: Chronic Kidney Disease, Proteinuria, Children
Sedes en Monterrey: Hospital Universitario "José Eleuterio González"
Ver registro oficial ↗ReclutandoNCT06307652
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Fase 3AstraZeneca
Condiciones: Heart Failure and Impaired Kidney Function
Sedes en Monterrey: Ver registro oficial
Ver registro oficial ↗ReclutandoNCT07227402
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
Fase 3Merck Sharp & Dohme LLC
Condiciones: Renal Cell Carcinoma
Sedes en Monterrey: I CAN ONCOLOGY CENTER S.A. DE C.V. ( Site 0507)
Ver registro oficial ↗ReclutandoNCT07662135
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
Fase 3AstraZeneca
Condiciones: Type 2 Diabetes Mellitus, Type 2 Diabetes With Chronic Kidney Disease
Sedes en Monterrey: Ver registro oficial
Ver registro oficial ↗ReclutandoNCT07753993
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
Fase 3AstraZeneca
Condiciones: Chronic Kidney Disease
Sedes en Monterrey: Ver registro oficial
Ver registro oficial ↗ReclutandoNCT05485961
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Fase 2 / Fase 3CSL Behring
Condiciones: End Stage Kidney Disease
Sedes en Monterrey: Servicios de Oncologia Medica SA de CV (Renal Center)
Ver registro oficial ↗ReclutandoNCT06858319
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
Fase 3Novartis Pharmaceuticals
Condiciones: Kidney Diseases, Kidney Diseases, Chronic, Urological Diseases
Sedes en Monterrey: Novartis Investigative Site
Ver registro oficial ↗